基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 PI3K/Akt/mTOR抑制剂(PI3K/Akt/mTOR) PI3K 抑制剂 N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 化合物 PIK-90
  • 化合物 PIK-90|T2461|TargetMol

化合物 PIK-90|T2461|TargetMol

PIK-90
677338-12-4
196 1mg 起订
435 5mg 起订
717 10mg 起订
上海 更新日期:2024-09-29

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 PIK-90
英文名称:
PIK-90
CAS号:
677338-12-4
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
≥95%
产品类别:
抑制剂
货号:
T2461

Product Introduction

Bioactivity

NamePIK-90
DescriptionPIK-90, a DNA-PK and PI3K inhibitor, suppresses p110α( IC50=11 nM), p110γ(IC50=18 nM) and DNA-PK(IC50=13 nM) .
Cell ResearchFor viabilty, cells are seeded in 12-well plates in the presence of PIK-90 for 3 days. Cell viability is determined using a WST-1 assay.(Only for Reference)
Kinase AssayExpression and Assay of p110α/p85α, p110β/p85α, p110δ/p85α, and p110γ : IC50 values are measured using either a standard TLC assay for lipid kinase activity or a high-throughput membrane capture assay. Kinase reactions are performed by preparing a reaction mixture containing kinase, inhibitor (2% DMSO final concentration), buffer (25 mM HEPES, pH 7.4, 10 mM MgCl2), and freshly sonicated phosphatidylinositol (100 μg/mL). Reactions are initiated by the addition of ATP containing 10 μCi of γ-32P-ATP to a final concentration 10 μM or 100 μM, and allowed to proceed for 20 minutes at room temperature. For TLC analysis, reactions are then terminated by the addition of 105 μL 1N HCl followed by 160 μL CHCl3:MeOH (1:1). The biphasic mixture is vortexed, briefly centrifuged, and the organic phase transferred to a new tube using a gel loading pipette tip precoated with CHCl3. This extract is spotted on TLC plates and developed for 3-4 hours in a 65:35 solution of n-propanol:1M acetic acid. The TLC plates are then dried, exposed to a phosphorimager screen, and quantitated. For each compound, kinase activity is typically measured at 10-12 inhibitor concentrations representing two-fold dilutions from the highest concentration tested (100 μM). For compounds showing significant activity, IC50 determinations are repeated two to four times, and the reported value is the average of these independent measurements.
In vitro胰岛素刺激的动物,PIK-90(10 mg/kg)处理,能够抑制由胰岛素刺激产生的血糖降低.
In vivo在慢性淋巴细胞白血病细胞中,PIK-90(1-10 μM )处理,抑制趋化性,明显抑制细胞迁移进入基质细胞层,降低CXCL12诱导的肌动蛋白聚合。在dHL60细胞中,PIK-90抑制fMLP刺激的Akt磷酸化,损害极性和趋化性。在胶质瘤细胞系中(U87 MG, SF188, SF763, LN229, A1207和LN-Z30细胞),PIK-90阻断Akt磷酸化,抑制细胞增殖。
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationEthanol : < 0.2 mg/mL (insoluble or slightly soluble)
DMSO : < 0.2 mg/mL (insoluble or slightly soluble), Sonication is recommended.
H2O : < 0.2 mg/mL (insoluble or slightly soluble)
KeywordsInhibitor | DNA-PK | PIK90 | PIK-90 | PI3K | Phosphoinositide 3-kinase | DNA-dependent protein kinase | PIK 90 | inhibit
Inhibitors Related(2S,3R,4S)-4-Hydroxyisoleucine | AS-605240 | Quercetin | Quercetin Dihydrate | Apilimod | Bimiralisib | GDC0084 | Myricetin | Duvelisib (R enantiomer) hydrochloride | Isoprenaline hydrochloride | Erucic acid | Sapanisertib
Related Compound LibrariesInhibitor Library | Bioactive Compound Library | Bioactive Compounds Library Max | Anti-Cancer Metabolism Compound Library | Anti-Pancreatic Cancer Compound Library | Kinase Inhibitor Library | Anti-Aging Compound Library | Anti-Ovarian Cancer Compound Library | Anti-Lung Cancer Compound Library | Glycolysis Compound Library
PIK-90|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 PIK-90相关厂家报价

  • PIK-90
  • PIK-90
  • 南京百鑫德诺生物科技有限公司
  • 2024-09-26
  • 询价
内容声明
拨打电话 立即询价